CVS Health Corp. (CVS)$93.26
Market Cap: 84.71 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for CVS Health Corp. (CVS).
HEALTHCARE
HEALTHCARE PLANS
DCF ready
Valuation
9.8x
EV/FCF, 10.2% FCF yield
Quality
2.4%
ROIC, 1.9% FCF margin
Growth
8.4%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 0.8x current ratio
Superinvestors
12
Top: Prem Watsa (10.0%)
Strengths to research
- Revenue compounded at 8.4% over five years.
- Debt/equity looks manageable at 0.0x.
- 12 tracked superinvestors report a position.
- 10 annual periods are available for trend analysis.
Watchouts
- P/E is elevated at 67.1x.
- Current ratio is below 1 at 0.8x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for CVS.
Grade B
66
/ 100
Peer Comparison
Target stock against 6 market-cap comparable peers.
Heat map: red worst to green best
| CVS Target | CVS Health Corp. | $84.7B | 67.1x | 9.8x | 2.4% | 8.4% | 1.9% | N/A | -0.9x | N/A |
| CI | Cigna Group | $89.8B | 12.9x | 8.6x | 14.3% | 11.4% | 3.5% | N/A | -0.6x | N/A |
| ELV | Elevance Health Inc. | $94.1B | 15.7x | 36.7x | 7.5% | 10.3% | 1.6% | N/A | 2.6x | N/A |
| HUM | Humana Inc. | $31.0B | 31.3x | 71.4x | 6.7% | 10.9% | 0.3% | N/A | -1.2x | N/A |
| CNC | Centene Corp. | $29.7B | -4.4x | 6.8x | -17.8% | 11.0% | 2.5% | 8.1% | N/A | N/A |
| UNH | United Health Group Inc. | $368.5B | 29.4x | 21.4x | 12.0% | 11.7% | 3.6% | N/A | -1.2x | N/A |
| MOH | Molina Healthcare Inc. | $17.3B | 20.6x | -20.6x | 11.6% | 18.5% | -1.4% | N/A | -4.4x | N/A |
Financial Charts
No financial data available for CVS (annual).
12 superinvestors own CVS
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Dodge & Cox Dodge & Cox | 51,780,116 | $3.7B | 2.05% | 0.0% |
| Richard Pzena Hancock Classic Value | 13,773,053 | $989M | 3.21% | 0.0% |
| Christopher Davis Davis Advisors | 12,239,666 | $879M | 4.04% | 0.0% |
| Prem Watsa Fairfax Financial Holdings | 2,712,000 | $195M | 10.03% | 0.0% |
| Samantha McLemore Patient Capital Management | 1,357,159 | $97M | 3.63% | 0.0% |
| John Rogers Ariel Appreciation Fund | 702,151 | $50M | 0.56% | 0.0% |
| Bill Nygren Oakmark Select Fund | 494,126 | $35M | 0.05% | 0.0% |
| Hillman Value Fund Hillman Value Fund | 67,462 | $5M | 3.36% | 0.0% |
| Robert Olstein Olstein Capital Management | 50,000 | $4M | 0.78% | 0.0% |
| Tweedy Browne Co. Tweedy Browne Value Fund | 19,132 | $1M | 0.11% | 0.0% |
| Lee Ainslie Maverick Capital | 9,472 | $680,000 | 0.01% | 0.0% |
| David Katz Matrix Asset Advisors | 6,175 | $443,000 | 0.04% | 0.0% |